Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Consideration Securities

14 Aug 2019 08:44

RNS Number : 0079J
Oilex Ltd
14 August 2019
 

ASX & AIM Announcement

 

14 August 2019

 

 

ASX: OEX

AIM: OEX

 

Re: Issue of Consideration Securities for Cooper-Eromanga Basins Acquisition

 

Oilex Ltd (Oilex or the Company) advises that it has today issued 9,166,333 ordinary shares at a deemed price of A$0.003 per share (Acquisition Shares) pursuant to the agreement with Terra Nova Energy (Australia) Pty Ltd and Perseville Investing Inc (collectively, TNP) to acquire a further 30.8330% participating interest in PEL112 and PEL444 as announced earlier today.

 

Today's acquisition together with the existing agreement with Holloman Energy Corporation (Holloman) as announced on 7 August 2019, will increase the Company's participating interest in PEL112 and PEL444 to 79.3333% when completed. Furthermore, today's agreement with TNP also provides the Company with an option, subject to certain terms and condition, to acquire a further 20.6667% and thereby increasing the Company's participating interest in PEL112 and PEL444 to 100%, when completed. Completion of the TNP and Holloman agreements is to occur on or before 30 September 2019.

 

The issue of the Acquisition Shares was pursuant to ASX Listing Rule 7.1.

 

AIM Admission and Total Voting Rights

 

Application has been made to the London Stock Exchange plc for the admission of the Acquisition Shares to trading on AIM (Admission). Admission of the Acquisition Shares is expected to become effective and dealings to commence at 8.00 a.m. on 21 August 2019. Following Admission of these shares, the Company will have 2,878,064,483 shares in issue. The Company does not currently hold any shares in treasury. Accordingly, the total number of voting rights will be 2,878,064,483.

 

Listing Rule 3.10.5A Disclosure

 

On 31 July 2019, the Company announced a £0.34 million equity capital raising and subsequently announced the applicable Appendix 3B for the issue of 257,329,999 shares on 13 August 2019 (Capital Raising Shares). As detailed in the Appendix 3B, the Company issued 237,355,731 shares pursuant to ASX Listing Rule 7.1A with the balance of 19,974,268 shares issued pursuant to ASX Listing Rule 7.1.

 

The Company provides the following information as required under ASX Listing Rule 3.10.5A in respect of the shares issued under the Company's 10% Placement Capacity under Listing Rule 7.1A.

 

a) The dilutive effect of the Placement under LR 7.1A on existing shareholders is as follows:

 

 

Number of shares on issue prior to the issue of the Placement Shares under LR7.1A:

 

- Excluding the 19,974,268 shares issued under LR7.1

2,611,568,151

- Including the 19,974,268 shares issued under LR7.1

2,631,542,419

 

 

Number of shares issued pursuant to LR7.1A

237,355,731

 

 

Dilutive effect of the share issue under LR 7.1A

 

- Excluding the 19,974,268 shares issued under LR7.1

8.33%

- Including the 19,974,268 shares issued under LR7.1

8.27%

 

b) The shares issued under Listing Rule 7.1A were issued to exempt, sophisticated and professional investors as it was considered to be the most efficient mechanism for raising funds at this time. Furthermore, the Company received attractive terms from the subscribers to the issue, well above that offered by the Company's brokers at the time.

 

c) There were no underwriting arrangements entered into pursuant to the capital raising.

 

d) Fees applicable to the placement including consulting fees were $10,000.

 

Section 708A(5)(e) Statement

 

Pursuant to the issue of the Acquisition Shares and Capital Raising Shares, Oilex gives notice under section 708A(5)(e) of the Corporations Act (Cth) (Act) that:

 

1) Oilex issued the shares without disclosure to investors under Part 6D.2 of the Act;

 

2) As at the date of this notice, Oilex has complied with:

a) the provisions of Chapter 2M of the Act as they apply to Oilex; and

b) section 674 of the Act; and

 

3) As at the date of this notice, there is no information that is 'excluded information' within the meaning of sections 708A(7) and 708(8) of the Act.

 

 

For and on behalf of Oilex Ltd

 

 

 

Mark Bolton

Chief Financial Officer Company Secretary

 

For further information, please contact:

Investor Enquiries

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230

UK

Media Enquiries (Aus)

Citadel-MAGNUS

Michael Weir

Email: mweir@citadelmagnus.com

Tel: +618 6160 4900

Australia

 

 

 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

 

Name of entity

 

OILEX LTD

 

ABN

 

50 078 652 632

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

Fully Paid Ordinary Shares

 

 

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

 

9,166,333 shares

 

 

 

 

3

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

 

Fully Paid Ordinary Shares

4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

Yes

 

 

 

 

 

 

5

Issue price or consideration

 

Deemed issue price of A$0.003 per share

 

 

 

 

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Consideration to acquire participating interest in PEL112 and PEL444

 

 

 

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

 

Yes

 

 

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

29 November 2018

 

 

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

9,166,333 shares 

 

 

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

Nil

 

 

 

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

Nil

 

 

 

6f

 

Number of +securities issued under an exception in rule 7.2

Not applicable

 

 

 

6g

If +securities issued under rule 7.1A was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

Not applicable

 

 

 

 

 

 

 

 

 

 

 

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

 

Not applicable

 

 

 

 

 

 

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

 

Listing Rule 7.1: 82,215,495

Listing Rule 7.1A: Nil

 

 

 

 

7

+Issue dates

Notes: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in appendix 7A.

 

Cross reference: item 33 of Appendix 3B.

 

14 August 2019

 

 

 

 

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

Number

+Class

 

2,878,064,483

 

 

Fully Paid Ordinary Shares

 

 

 

 

9

Number and +class of all +securities not quoted on ASX (including the securities in section 2 if applicable)

 

 

 

 

Number

+Class

 

60,664,887

 

 

2,222,222

 

 

6,666,667

 

Options

($0.004121, 1/10/2019)

 

Options

(£0.00225, 22/05/2020)

 

Options

(£0.0036, 24/12/2020)

 

 

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

 

Not applicable

        

 

 

 

 

Part 2 ‑ Pro rata issue

 

11

Is security holder approval required?

 

Not applicable

 

 

 

12

Is the issue renounceable or non-renounceable?

 

 

 

 

13

Ratio in which the +securities will be offered

 

 

 

 

14

+Class of +securities to which the offer relates

 

 

 

 

15

+Record date to determine entitlements

 

 

 

 

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

 

 

 

 

17

Policy for deciding entitlements in relation to fractions

 

 

 

 

 

18

Names of countries in which the entity has security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

 

 

 

 

19

Closing date for receipt of acceptances or renunciations

 

 

 

 

 

 

 

20

Names of any underwriters

 

 

 

 

 

 

21

Amount of any underwriting fee or commission

 

 

 

 

22

Names of any brokers to the issue

 

 

 

 

 

 

23

Fee or commission payable to the broker to the issue

 

 

 

 

 

 

 

 

 

 

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

 

 

 

 

25

If the issue is contingent on security holders' approval, the date of the meeting

 

 

 

 

26

Date entitlement and acceptance form and offer documents will be sent to persons entitled

 

 

 

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

 

 

 

 

28

Date rights trading will begin (if applicable)

 

 

 

 

29

Date rights trading will end (if applicable)

 

 

 

 

 

 

30

How do security holders sell their entitlements in full through a broker?

 

 

 

 

31

How do security holders sell part of their entitlements through a broker and accept for the balance?

 

 

 

 

32

How do security holders dispose of their entitlements (except by sale through a broker)?

 

 

 

 

33

+Issue date

 

 

     

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

(a)

ü

+Securities described in Part 1

 

 

 

(b)

o

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

Entities that have ticked box 34(a)

 

 

Additional securities forming a new class of securities

 

 

Tick to indicate you are providing the information or documents

 

 

 

 

35

 

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

 

36

 

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

 

37

 

A copy of any trust deed for the additional +securities

 

 

 

Entities that have ticked box 34(b)

 

 

38

Number of securities for which +quotation is sought

 

 

 

 

 

39

+Class of +securities for which quotation is sought

 

 

 

 

 

40

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

 

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another +security, clearly identify that other +security)

 

 

     
 

 

 

 

 

42

Number and +class of all +securities quoted on ASX (including the securities in clause 38)

 

 

Number

+Class

 

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

·; The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

·; There is no reason why those +securities should not be granted +quotation.

 

·; An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·; Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

·; If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

Mark Bolton

Company Secretary

Date: 14 August 2019

 

 

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities

Introduced 01/08/12, Amended 04/03/13

 

Part 1

 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue

 

2,001,968,379 shares

 

Add the following:

• Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2

 

 

90,190,999 shares (Issued 16/11/18)

10,000,000 shares (Issued 5/12/18)

 

·; Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval

 

157,894,737 shares (Issued 17/09/2018)

10,843,344 shares (Issued 26/09/2018)

91,222,451 shares (Issued 26/09/2018)

3,467,070 shares (Issued 26/09/2018)*

1,724,904 shares (Issued 29/11/2018)*

2,772,864 shares (Issued 01/04/2019)^

3,472,569 shares (Issued 18/06/2019)^

 

 

* approved by shareholders on 29/11/2017

^ approved by shareholders on 29/11/2018

• Number of partly paid +ordinary securities that became fully paid in that 12 month period

Nil

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

Subtract the number of fully paid +ordinary securities cancelled during that 12 month period

Nil

"A"

2,373,557,317

 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

356,033,597

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

29,120,559 shares (Issued 14/12/2018)

71,527,778 shares (Issued 21/12/2018)

4,291,667 options (Issued 21/12/2018)

39,583,333 shares (Issued 21/12/2018)

2,375,000 options (Issued 21/12/2018)

55,555,556 shares (Issued 21/12/2018)

13,888,889 shares (Issued 18/01/2019)

1,760,000 shares (Issued 01/04/2019)

2,324,569 shares (Issued 18/06/2019)

24,250,150 shares (Issued 07/08/2019)

19,974,268 shares (Issued 13/08/2019)

9,166,333 shares (Issued 14/08/2019)

 

"C"

273,818,102

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

356,033,597

Subtract "C"

Note: number must be same as shown in Step 3

273,818,102

Total ["A" x 0.15] - "C"

 

82,215,495

 

[Note: this is the remaining placement capacity under rule 7.1]

 

 

 

Part 2

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

2,373,557,317

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

237,355,731

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

 

 

237,355,731 shares (Issued 13/08/2019)

"E"

237,355,731

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

237,355,731

Subtract "E"

Note: number must be same as shown in Step 3

237,355,731

Total ["A" x 0.10] - "E"

Nil

Note: this is the remaining placement capacity under rule 7.1A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOESFUSWLFUSEDA
Date   Source Headline
27th Jul 202210:54 amRNSCambay C-77H Re-frac Operations Update No5
26th Jul 20227:54 amRNSChange of Company Name
25th Jul 20227:44 amRNSCambay C-77H Re-frac Operations Update No4
25th Jul 20227:40 amRNSJune 2022 Quarterly Report
25th Jul 20227:30 amRNSSuspension - Oilex Ltd
25th Jul 20227:21 amRNSSuspension of trading on AIM
22nd Jul 20229:21 amRNSPlacement - Issue of Securities and TVR
21st Jul 20227:00 amRNSCambay C-77H Re-frac Operations Update No3
19th Jul 20227:55 amRNSChange of Company Name & AIM Suspension
18th Jul 20229:34 amRNSCambay C-77H Re-frac Operations Update No2
13th Jul 202211:18 amRNSResults of General Meeting
30th Jun 20221:57 pmRNSDirector Dealing
23rd Jun 20227:00 amRNSCambay C-77H Re-frac Operations Update
13th Jun 20227:00 amRNSName Change, Director Option Award, Notice of GM
9th Jun 202212:25 pmRNSHolding(s) in Company
8th Jun 20227:00 amRNSHolding(s) in Company
6th Jun 20227:00 amRNSCambay Production and Operations Update
1st Jun 20229:00 amRNSHolding(s) in Company
1st Jun 20227:00 amRNSPlacement - Issue of Securities
27th May 20227:00 amRNSCambay Reserves Re-classification
17th May 20227:00 amRNSChange of Company Secretary
4th May 20227:00 amRNSCambay Production Update and Fund Raise
28th Apr 20227:00 amRNSMarch Quarterly Report 2022
14th Apr 20222:06 pmRNSSecond Price Monitoring Extn
14th Apr 20222:00 pmRNSPrice Monitoring Extension
14th Apr 20227:00 amRNSCambay India Re-frac Update & Revised Gas Contract
8th Apr 20229:38 amRNSCambay India Production and C-77H Re-frac Update
7th Apr 20224:41 pmRNSSecond Price Monitoring Extn
7th Apr 20224:35 pmRNSPrice Monitoring Extension
4th Apr 202211:16 amRNSCambay India Production Further Update
4th Apr 20227:00 amRNSCambay India Production Update
25th Mar 202210:16 amRNSChange in Substantial Holding
22nd Mar 20227:00 amRNSIssue of Securities and Cleansing Notice
16th Mar 20227:00 amRNSCambay India Update
11th Mar 202211:00 amRNSHalf Year Report 2021
28th Feb 20227:00 amRNSMedway Hub CCS Project
18th Feb 20227:00 amRNSResults of General Meeting
15th Feb 20224:41 pmRNSSecond Price Monitoring Extn
15th Feb 20224:36 pmRNSPrice Monitoring Extension
15th Feb 20222:01 pmRNSPrice Monitoring Extension
11th Feb 20224:42 pmRNSSecond Price Monitoring Extn
11th Feb 20224:36 pmRNSPrice Monitoring Extension
10th Feb 202211:06 amRNSSecond Price Monitoring Extn
10th Feb 202211:01 amRNSPrice Monitoring Extension
7th Feb 20224:19 pmRNSGrant of Environmental Clearance for Cambay Field
7th Feb 20227:00 amRNSCambay PSC Participating Interest Assignment
4th Feb 20224:41 pmRNSSecond Price Monitoring Extn
4th Feb 20224:37 pmRNSPrice Monitoring Extension
4th Feb 20222:06 pmRNSSecond Price Monitoring Extn
4th Feb 20222:01 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.